Evidence map›Paper›PMID 32730093›Full record

ArticleAmerican journal of respiratory and critical care medicine2021

Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development.

Warapen Treekitkarnmongkol, Maya Hassane, Ansam Sinjab, Kyle Chang, Kieko Hara, Zahraa Rahal, Jiexin Zhang, Wei Lu, Smruthy Sivakumar, Tina L McDowell and 22 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Lipocalin-2 and intestinal diseases.World journal of gastroenterology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. ZNF143 Expression is Associated with COPD and Tumor Microenvironment in Non-Small Cell Lung Cancer.International journal of chronic obstructive pulmonary disease · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 5 institutions in 4 countries.

Warapen TreekitkarnmongkolDepartment of Translational Molecular Pathology.
Maya HassaneDepartment of Biochemistry and Molecular Genetics and.
Ansam SinjabDepartment of Translational Molecular Pathology.
Kyle ChangDepartment of Epidemiology.
Kieko HaraDepartment of Translational Molecular Pathology.
Zahraa RahalFaculty of Medicine, American University of Beirut, Beirut, Lebanon.
Jiexin ZhangDepartment of Bioinformatics and Computer Biology.
Wei LuDepartment of Translational Molecular Pathology.
Smruthy SivakumarDepartment of Epidemiology.
Tina L McDowellDepartment of Translational Molecular Pathology.
Jacob KantrowitzSection of Computational Biomedicine, School of Medicine, Boston University, Boston, Massachusetts; and.
Jianling ZhouDepartment of Translational Molecular Pathology.
Wenhua LangDepartment of Translational Molecular Pathology.
Li XuDepartment of Translational Molecular Pathology.
Joshua K OchiengDepartment of Translational Molecular Pathology.
Sayuri Nunomura-NakamuraGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Shanshan DengDepartment of Pulmonary Medicine.
Carmen BehrensDepartment of Translational Molecular Pathology.
Maria Gabriela RasoDepartment of Translational Molecular Pathology.
Junya FukuokaGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Alexandre ReubenDepartment of Thoracic Head and Neck Medical Oncology.
Edwin J OstrinDepartment of General Internal Medicine, and.
Edwin ParraDepartment of Translational Molecular Pathology.
Luisa M SolisDepartment of Translational Molecular Pathology.
Avrum E SpiraSection of Computational Biomedicine, School of Medicine, Boston University, Boston, Massachusetts; and.
Florencia McAllisterDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Tina CasconeDepartment of Thoracic Head and Neck Medical Oncology.
Ignacio I WistubaDepartment of Translational Molecular Pathology.
Seyed Javad MoghaddamDepartment of Pulmonary Medicine.
Paul A ScheetDepartment of Epidemiology.
Junya FujimotoDepartment of Translational Molecular Pathology.
Humam KadaraDepartment of Translational Molecular Pathology.
Boston University · USUniversity of Nagasaki · JPAmerican University of Beirut · LBGeneral Department of Preventive Medicine · VNThe University of Texas MD Anderson Cancer Center · US

Funding

(PQ1) Progression of the airway field of injury to Kras mutant lung cancerR01CA205608 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KADARA, HUMAM, SCHEET, PAUL A · 2016 to 2019
$1.4M
NCI NIH HHS R01 CA205608
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenocarcinoma of LungAnimalsAntineoplastic AgentsBiomarkersFemaleGene Expression RegulationHumansLipocalin-2Lung NeoplasmsMaleMicePulmonary Disease, Chronic ObstructiveRNA, MessengerAntineoplastic AgentsBiomarkersLipocalin-2RNA, Messengerchronic obstructive pulmonary diseaseimmunitylipocalin-2lung neoplasms

Identifiers

PMID32730093
PMCPMC7781147
OpenAlexW3046458349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.